Avatar of Braxton Norwood.
Braxton Norwood
Co-Founder, CEO @ Lutroo Imaging | Pharmacologist & Entrepreneur
ProfilePortfolio
Posts
0Connections
Print
Avatar of the user.

Braxton Norwood

Co-Founder, CEO @ Lutroo Imaging | Pharmacologist & Entrepreneur
As a healthcare and pharmacology entrepreneur in Billings, Montana, Braxton Norwood has deep experience in science, medicine, and business. Braxton Norwood has established a notable track record of founding and leading innovative biopharma and medtech companies throughout his career. He is the driving force behind four successful ventures: including, Redpoint Imaging LLC and Lutroo Imaging. Each company reflects its commitment to advancing medical technology and improving patient care. In addition to his entrepreneurial successes, Braxton co-founded the Unbreakables Foundation. This organization is dedicated to enhancing the lives of underserved communities in the United States and former conflict zones. Through the foundation, Braxton and his team work to provide critical support and resources to those in need. To learn more about Braxton Norwood, visit braxtonnorwood.net or braxtonnorwood.com
Unbreakables Foundation
University of Arizona
Billings Metropolitan Area, Yellowstone, State of Montana, United States
United States

Professional Background

  • Current status
    Employed
    Open to opportunities
  • Profession
  • Fields
  • Work experience
    More than 15 years relevant
  • Management
  • Highest level of education

Job search preferences

  • Desired job type
    Not interested in working remotely
  • Desired positions
    Co-Founder, CEO
  • Desired work locations
  • Freelance

Work Experience

Co-Founder

Aug 2023 - Present
Billings, Yellowstone County, Montana, United States
Unbreakables is a 501(c)(3) nonprofit that exists to help give those at the greatest disadvantage the chance for a brighter future. Our purpose is to improve the welfare and self-reliance of people living underprivileged lives, both in the United States and former conflict zones. https://unbreakables.org https://www.facebook.com/unbreakables.foundation https://braxtonnorwood.org

Co-Founder, CEO

Dec 2021 - Present
Kalispell, Flathead County, Montana, United States
Lutroo Imaging is developing a proprietary PET radiotracer that enables pain visualization for the first time. This will make pain diagnosis faster, cheaper, and more accurate, thereby dramatically improving pain care and quality of life. By being able to see the pain source, healthcare professionals will be able to treat it appropriately with earlier, targeted therapy. https://lutrooimaging.com

Co-Founder

Jul 2020 - Present
Montana, United States
Redpoint Imaging is a nuclear medicine company focused on providing radiotracers to an under-served healthcare market. Primary customer benefits, which result in substantially improved patient care and increased hospital revenue, are greater radiotracer availability & lower costs. Identified the opportunity, secured funding, formed the team; co-led deal structuring and partnership formation.

Founder, CEO

Jan 2016 - Jan 2021
5 yrs 1 mo
Montana, United States
Expesicor was focused on preventing, treating, and curing neurological disorders/injuries, e.g. Alzheimer's Disease, TBI, CTE, and Epilepsy. Led efforts to secure over $4.5M in private funding (angel and VC) and grants from multiple sources (including the National Institutes of Health). Principal Investigator on three SBIR grants. Increased company valuation by 250% in eighteen months. Quadrupled headcount in under three years. Experienced in drug discovery/development, having conceived and led projects from discovery stage to Phase II clinical trials. Established productive collaborations/partnerships with leading researchers and universities. Developed an IP portfolio including multiple pending and granted patents, trademarks, and IP in-licensed from universities/companies.

Director, Experimental Epilepsy

Apr 2010 - Aug 2017
7 yrs 5 mos
Landkreis Marburg-Biedenkopf, Regierungsbezirk Gießen, Hesse, Germany
I established and led a translational epilepsy research laboratory. Our primary goal was to develop the first disease-modifying therapies for epilepsy. I quickly grew the lab from one scientist (me) to three scientists, one technician, a part-time physician-scientist, and multiple students. As a primary or co-investigator on over $10M in grant funding, we collaborated with leading scientists in Europe, USA, and South America, and published nearly two-dozen peer-reviewed studies.

Consulting Ontologist

Dec 2007 - Dec 2012
5 yrs 1 mo

Education

Medical Pharmacology
2004 - 2009
Description
Neuroscience minor
Anthropology
2000 - 2004
Activities and societies
Alpha Lambda Delta national honor society
Description
Minors: Biochemistry (4.0 GPA), Pre-medicine